AspireAssist

Aspiration Therapy System

FDA Premarket Approval P150024 S010

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of the revised protocol with modifications including use of local labs for blood work, changes to the minimum and maximum number of patients enrolled per site, and a revised study timeline for the post-approval study (pas) protocol.

DeviceAspireAssist
Classification NameAspiration Therapy System
Generic NameAspiration Therapy System
ApplicantASPIRE BARIATRICS INC
Date Received2018-05-01
Decision Date2019-01-15
PMAP150024
SupplementS010
Product CodeOYF
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product No
Applicant Address ASPIRE BARIATRICS INC 3200 Horizon Drive suite 100 king Of Prussia, PA 19406

Supplemental Filings

Supplement NumberDateSupplement Type
P150024Original Filing
S016 2019-10-29 Normal 180 Day Track No User Fee
S015
S014
S013
S012 2018-09-25 Special (immediate Track)
S011 2018-05-22 Special (immediate Track)
S010 2018-05-01 Normal 180 Day Track No User Fee
S009 2018-02-07 Special (immediate Track)
S008 2018-01-19 Normal 180 Day Track
S007
S006 2017-03-27 Real-time Process
S005 2016-10-17 Normal 180 Day Track No User Fee
S004 2016-08-16 Real-time Process
S003 2016-08-15 Special (immediate Track)
S002
S001 2016-07-29 Special (immediate Track)

NIH GUDID Devices

Device IDPMASupp
10857808005471 P150024 000
10857808005044 P150024 000
10857808005037 P150024 000
10857808005020 P150024 000
10857808005013 P150024 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.